Form 8.3 - Horizon Therapeutics plc

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

6th February 2023

2. INTERESTS AND SHORT POSITIONS

  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,856,200

(2.123%)

44,283

(0.019%)

(2) Derivatives (other than options)

 

621

(0.000%)

(3) Options and agreements to purchase/sell

75,000

(0.033%)

152,200

(0.067%)

Total

4,931,200

(2.156%)

197,104

(0.086%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

  1. DEALINGS (Note 4)
  1. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Sale

2,990

110.12

Sale

1,400

110.15

Sale

11,805

110.11

Sale

4,838

110.18

Purchase

976

110.23

Sale

3,700

110.23

Sale

3,673

110.08

Sale

510

110.17

Sale

2,754

110.16

Purchase

100

110.29

Sale

39

110.29

Sale

2,109

110.05

Sale

151

110.13

Sale

10,431

110.10

Sale

3,830

110.24

Sale

209

110.34

Sale

1,956

110.25

Sale

6,288

110.19

Sale

3,113

110.21

Sale

667

110.31

Sale

4,342

110.27

Purchase

100

110.20

Sale

1,424

110.20

Sale

234

110.01

Sale

801

110.35

Purchase

78

110.26

Sale

1,000

110.26

Sale

3,973

110.04

Sale

6,003

110.22

Sale

92

109.90

Purchase

800

109.80

Sale

100

109.80

Sale

200

110.33

Sale

446

110.30

Sale

2,507

110.28

Purchase

3,050

109.79

Sale

160

109.79

Sale

6,295

110.09

Sale

102

109.92

Purchase

150

109.78

Sale

1,000

110.03

Sale

1,204

110.07

Purchase

484

110.00

Sale

2,600

110.00

Sale

8,939

110.06

Sale

100

109.84

Sale

182

109.86

Sale

100

109.97

Sale

50

109.77

Purchase

400

109.98

Sale

50

109.73

Sale

51

109.72

Sale

50

109.88

Sale

150

109.85

Sale

50

109.76

Sale

906

110.11

Sale

33

110.23

Sale

35

110.08

Purchase

1,228

110.25

Sale

22

110.27

Sale

5

110.20

Sale

78

110.26

Sale

168

110.04

Sale

6

110.06

Sale

6

110.02

Sale

302

109.87

Sale

39

110.08

Sale

45

110.17

Sale

4

110.32

Purchase

318

110.25

Sale

118

110.25

Sale

39

110.19

Sale

13

110.21

Sale

13

110.03

Sale

13

110.07

Sale

152

110.00

Purchase

100

110.14

Sale

404

110.14

Purchase

600

110.12

Sale

200

110.15

Purchase

1,041

110.11

Purchase

500

110.18

Sale

1,000

110.18

Sale

3,926

110.23

Purchase

100

110.08

Sale

61

110.08

Sale

3,551

110.17

Sale

2,101

110.16

Purchase

200

110.32

Purchase

200

110.10

Sale

300

110.10

Sale

8,473

110.24

Purchase

733

109.95

Purchase

588

110.25

Sale

19,452

110.25

Sale

5,199

110.19

Purchase

1,020

110.21

Sale

5,099

110.21

Sale

500

110.31

Purchase

322

110.27

Sale

1,774

110.27

Purchase

1,285

110.20

Sale

500

110.20

Sale

80

110.01

Purchase

100

110.35

Purchase

700

110.26

Sale

500

110.26

Purchase

100

110.04

Sale

25

110.04

Purchase

1,971

110.22

Sale

18,018

110.22

Purchase

400

109.90

Sale

2,704

109.90

Purchase

300

109.89

Sale

1,846

109.89

Purchase

3,000

109.80

Sale

600

110.30

Sale

3,400

110.28

Purchase

952

110.09

Purchase

133

109.92

Purchase

1,707

110.00

Purchase

500

110.06

Sale

39

110.06

Purchase

564

109.97

Purchase

300

109.96

Sale

80

109.96

Sale

130

109.87

Purchase

975

109.98

Purchase

1,093

109.93

Purchase

300

109.88

Purchase

442

109.99

Sale

105

109.99

Purchase

4,550

109.83

Sale

4,550

109.83

Purchase

800

109.94

Purchase

300

109.91

Sale

100

110.45

Purchase

2,192

110.14

Sale

5

110.14

Purchase

54

110.15

Sale

1,456

110.08

Sale

32

110.22

Sale

1,172

110.28

Purchase

47

109.96

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

 

 

 

 

c. Options transactions in respect of existing relevant securities

  1. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

d. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

               None.

 

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

7th February 2023

Contact name

Roisin Nagle

Telephone number

+44 203 192 8746

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Call Option

Written

29,000

110.00

American

2/17/2023

IE00BQPVQZ61

Call Option

Purchased

29,100

100.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

1,500

90.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

3,000

110.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Written

3,000

115.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

42,500

120.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

400

115.00

American

3/17/2023

IE00BQPVQZ61

Put Option

Purchased

400

115.00

American

3/17/2023

IE00BQPVQZ61

Put Option

Purchased

3,500

110.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

62,400

110.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

4,100

80.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

3,500

110.00

American

3/17/2023

IE00BQPVQZ61

Put Option

Purchased

3,100

85.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

2,500

90.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

100

95.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

23,800

100.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

14,500

105.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

400

80.00

American

1/17/2025

IE00BQPVQZ61

Put Option

Purchased

400

90.00

American

1/19/2024

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET
Sequence Number: 1059801
Time of Receipt (offset from UTC): 20230207T143806+0000

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.